PV-10 Chemoablation of Recurrent Breast Carcinoma

Summary

The objective of this study is to investigate the safety of intralesional (IL) PV-10 for the treatment of recurrent breast carcinoma. This study will also include a preliminary assessment of response of injected lesions by histologic assessment upon lesion excision at 1-3 weeks following IL PV-10 administration. Post-excision wound healing will be assessed clinically at 1 week and 4 weeks following excision of PV-10 injected lesions.

Timeline

Start

2005-10

Primary completion

2008-06

Completion

2008-07

Drugs

Indications